DDA Proteomics
DDA proteomics is a widely utilized mass spectrometry technique in proteomics research. It selectively analyzes peptides within a sample to identify and quantify proteins. The fundamental principle of DDA proteomics involves the mass spectrometer scanning target samples and acquiring data in a data-dependent mode. This method can identify and characterize numerous proteins in a single experiment, providing crucial insights into dynamic changes within biological systems. DDA proteomics is instrumental in protein identification, quantitative mass analysis, and protein modification identification. In drug development, DDA proteomics is employed to analyze drug-target interactions, elucidate mechanisms of action, and optimize drug design. In disease diagnostics, DDA proteomics can analyze patient samples to identify disease-associated protein expression profiles, aiding in early diagnosis and personalized treatment. Additionally, DDA proteomics tracks protein dynamics within organisms, monitoring changes in protein expression in various cellular environments and studying cell signaling pathways.
Principles of DDA Proteomics
DDA proteomics hinges on a two-step process during data acquisition via a mass spectrometer:
1. Primary Mass Spectrometry (MS1)
(1) The mass spectrometer scans all peptides in the sample, generating a comprehensive precursor ion spectrum.
(2) The MS1 phase records the mass-to-charge ratio (m/z) and relative abundance of precursor ions.
2. Secondary Mass Spectrometry (MS2)
(1) From MS1, high-abundance precursor ions are selected, triggering fragmentation (e.g., collision-induced dissociation, CID) to produce fragment ions.
(2) The MS2 phase captures fragment ion data for peptide and protein identification.
(3) The DDA method prioritizes higher abundance ions, which may overlook lower-abundance ions. This selectivity benefits qualitative analysis but can introduce quantitative bias.
Core Methods and Technical Processes
1. Sample Preparation
Proteins are extracted from biological samples, denatured, and digested enzymatically to yield peptides suitable for mass spectrometry.
2. Separation Techniques
Liquid chromatography, such as high-performance liquid chromatography (HPLC), is used to separate peptides, reducing sample complexity and enhancing mass spectrometry sensitivity and resolution.
3. Mass Spectrometry Analysis
Peptides are ionized using electrospray or matrix-assisted laser desorption ionization and analyzed by a mass spectrometer. In DDA mode, the strongest peptide signals are automatically selected for fragmentation, acquiring their mass spectra.
4. Data Analysis
Bioinformatics software is employed to process the mass spectrometry data, using database searches to match known protein databases for identification and quantification.
Advantages of DDA Proteomics
1. High-Throughput Identification
Capable of identifying thousands of proteins in a single experiment, suitable for large-scale proteomics studies.
2. High Flexibility
Applicable to a wide variety of biological samples, including cells, tissues, and body fluids.
3. High Sensitivity and Resolution
Capable of detecting low-abundance proteins and conducting detailed analysis of protein modifications.
4. Strong Reliability
Provides accurate protein identification through database comparisons.
MtoZ Biolabs offers state-of-the-art DDA proteomics analysis services for researchers, supported by a proficient team and efficient analytical platform. Our services encompass protein identification, quantitative analysis, and comprehensive analysis of complex biological samples, facilitating breakthroughs in scientific research. We invite collaboration to leverage our expertise.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
